Assembly Biosciences Inc (ASMB) Stock Analysis
Verdict: HOLD
Investment score: 62/100
Analysis as of
Is Assembly Biosciences Inc stock worth reviewing? The TradeMates thesis
Assembly Bio is in a transition phase, backed by Gilead, with improving financials but high price volatility.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 75/100 (weight 15%)
- Technical Momentum: 48/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 70/100 (weight 10%)
Assembly Biosciences Inc opportunities and risks
What speaks for ASMB
- Gilead Strategic Partnership
What speaks against ASMB
- Clinical Trial Failure
Peers and competitors
Frequently asked questions about Assembly Biosciences Inc (ASMB)
Is ASMB stock a good investment?
The TradeMates model rates Assembly Biosciences Inc as HOLD with an investment score of 62/100. Assembly Bio is in a transition phase, backed by Gilead, with improving financials but high price volatility. This is algorithmic model output, not personal investment advice.
Is ASMB stock a buy?
The TradeMates model verdict for ASMB is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.